Skip to main content

Advertisement

SpringerLink
Log in

Unmasking of incipient amyotrophic lateral sclerosis by botulinum toxin therapy

  • Letter to the Editors
  • Published:
Journal of Neurology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Tan E, Lo Y, Auchus A (2001) Recurrent jaw dislocation after botulinum toxin treatment for sialorrhoea in amyotrophic lateral sclerosis. J Neurol Sci 190(1–2):95–97

    Article  PubMed  CAS  Google Scholar 

  2. Winterholler M, Erbguth F (2001) Botulinum toxin for the treatment of sialorrhoea in ALS: serious side effects of a transductal approach. JNNP 70:417–418

    CAS  Google Scholar 

  3. Meijer J, van Kuijk A, Zwarts M (2008) Acute deterioration of bulbar function after botulinum toxin treatment for sialorrhoea in amyotrophic lateral sclerosis. Am J Phys Med Rehabil 87(4):321–324

    Article  PubMed  Google Scholar 

  4. Erbguth F, Claus D, Engelhardt A, Dressler D (1993) Systemic effect of local botulinum toxin injections unmasks subclinical Lambert–Eaton myasthenic syndrome. JNNP 56(11):1235–1236

    CAS  Google Scholar 

  5. Dressler D (2010) Subclinical myasthenia gravis causing increased sensitivity to botulinum toxin therapy. J Neural Transm 117:1293–1294

    Article  PubMed  CAS  Google Scholar 

  6. Gioltzoglou T, Cordivari C, Lees A (2005) Problems with botulinum toxin treatment in mitochondrial cytopathy: case report and review of the literature. JNNP 76:1594–1596

    CAS  Google Scholar 

  7. Girlanda P, Vita G, Messina C (1992) Botulinum toxin therapy: distant effects on neuromuscular transmission and autonomic nervous system. JNNP 55:844–845

    CAS  Google Scholar 

  8. Crowner B, Torres-Russotto D, Racette B (2010) Systemic weakness after therapeutic injections of botulinum toxin A: a case series and review of the literature. Clin Neuropharmacol 33(5):243–247

    Article  PubMed  CAS  Google Scholar 

Download references

Conflicts of interest

On behalf of all authors, the corresponding author states that there is no conflict of interest.

Ethical standard

The authors declare that they acted in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki.

Author information

Authors and Affiliations

  1. Department of Neurology, John Radcliffe Hospital, Oxford, UK

    Louisa Kent, Paul Davies, Robin Kennett, Sunil Wimalaratna, Richard Kerr, Martin R. Turner & Kevin Talbot

Authors
  1. Louisa Kent
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Paul Davies
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Robin Kennett
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Sunil Wimalaratna
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Richard Kerr
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Martin R. Turner
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Kevin Talbot
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Kevin Talbot.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kent, L., Davies, P., Kennett, R. et al. Unmasking of incipient amyotrophic lateral sclerosis by botulinum toxin therapy. J Neurol 260, 1166–1167 (2013). https://doi.org/10.1007/s00415-013-6854-x

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00415-013-6854-x

Keywords

Search

Navigation